339 related articles for article (PubMed ID: 33514403)
1. A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis.
Li L; Ugalde AP; Scheele CLGJ; Dieter SM; Nagel R; Ma J; Pataskar A; Korkmaz G; Elkon R; Chien MP; You L; Su PR; Bleijerveld OB; Altelaar M; Momchev L; Manber Z; Han R; van Breugel PC; Lopes R; Ten Dijke P; van Rheenen J; Agami R
Genome Biol; 2021 Jan; 22(1):54. PubMed ID: 33514403
[TBL] [Abstract][Full Text] [Related]
2. A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer.
Zhu C; Li L; Zhang Z; Bi M; Wang H; Su W; Hernandez K; Liu P; Chen J; Chen M; Huang TH; Chen L; Liu Z
Mol Cell; 2019 Aug; 75(4):791-806.e8. PubMed ID: 31303470
[TBL] [Abstract][Full Text] [Related]
3. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis.
Marquard S; Thomann S; Weiler SME; Bissinger M; Lutz T; Sticht C; Tóth M; de la Torre C; Gretz N; Straub BK; Marquardt J; Schirmacher P; Breuhahn K
Cell Commun Signal; 2020 Oct; 18(1):166. PubMed ID: 33097058
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth.
Zanconato F; Forcato M; Battilana G; Azzolin L; Quaranta E; Bodega B; Rosato A; Bicciato S; Cordenonsi M; Piccolo S
Nat Cell Biol; 2015 Sep; 17(9):1218-27. PubMed ID: 26258633
[TBL] [Abstract][Full Text] [Related]
5. TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma.
Zhang J; Liu P; Tao J; Wang P; Zhang Y; Song X; Che L; Sumazin P; Ribback S; Kiss A; Schaff Z; Cigliano A; Dombrowski F; Cossu C; Pascale RM; Calvisi DF; Monga SP; Chen X
Am J Pathol; 2019 May; 189(5):1077-1090. PubMed ID: 30794805
[TBL] [Abstract][Full Text] [Related]
6. The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1.
Wang C; Nie Z; Zhou Z; Zhang H; Liu R; Wu J; Qin J; Ma Y; Chen L; Li S; Chen W; Li F; Shi P; Wu Y; Shen J; Chen C
Oncotarget; 2015 Jul; 6(19):17685-97. PubMed ID: 25970772
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway.
Liu H; Zhang S; Liu Y; Ma J; Chen W; Yin T; Li T; Liang B; Tao L
Respir Res; 2022 Aug; 23(1):209. PubMed ID: 35986277
[TBL] [Abstract][Full Text] [Related]
8. Upregulated YAP promotes oncogenic CTNNB1 expression contributing to molecular pathology of hepatoblastoma.
Lu S; Jiang M; Chen Q; Luo X; Cao Z; Huang H; Zheng M; Du J
Pediatr Blood Cancer; 2022 Sep; 69(9):e29705. PubMed ID: 35404538
[TBL] [Abstract][Full Text] [Related]
9. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner.
Liu Y; Wang G; Yang Y; Mei Z; Liang Z; Cui A; Wu T; Liu CY; Cui L
Oncogene; 2016 May; 35(21):2789-800. PubMed ID: 26387538
[TBL] [Abstract][Full Text] [Related]
10. TRAM2 promotes the malignant progression of glioma through PI3K/AKT/mTOR pathway.
Gao X; Jiang W; Ke Z; Huang Q; Chen L; Zhang G; Li C; Yu X
Biochem Biophys Res Commun; 2022 Jan; 586():34-41. PubMed ID: 34826698
[TBL] [Abstract][Full Text] [Related]
11. HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway.
Geng H; Liu G; Hu J; Li J; Wang D; Zou S; Xu X
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396425
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family Members.
Coto-Llerena M; Tosti N; Taha-Mehlitz S; Kancherla V; Paradiso V; Gallon J; Bianco G; Garofoli A; Ghosh S; Tang F; Ercan C; Christofori GM; Matter MS; Droeser RA; Zavolan M; Soysal SD; von Flüe M; Kollmar O; Terracciano LM; Ng CKY; Piscuoglio S
Hepatol Commun; 2021 Apr; 5(4):661-674. PubMed ID: 33860124
[TBL] [Abstract][Full Text] [Related]
13. The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum/glucocorticoid regulated kinase 1 (SGK1).
He S; Zhang H; Xiao Z; Bhushan S; Gao K; Wang W
Bioengineered; 2021 Dec; 12(1):601-614. PubMed ID: 33517828
[TBL] [Abstract][Full Text] [Related]
14. OTUD6A orchestrates complex modulation of TEAD4-mediated transcriptional programs.
Kim HJ; Choi Y; Lee Y; Hwangbo M; Kim J
FEBS Lett; 2024 May; 598(9):1045-1060. PubMed ID: 38594215
[TBL] [Abstract][Full Text] [Related]
15. YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers.
Galli GG; Carrara M; Yuan WC; Valdes-Quezada C; Gurung B; Pepe-Mooney B; Zhang T; Geeven G; Gray NS; de Laat W; Calogero RA; Camargo FD
Mol Cell; 2015 Oct; 60(2):328-37. PubMed ID: 26439301
[TBL] [Abstract][Full Text] [Related]
16. TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells.
Elster D; Tollot M; Schlegelmilch K; Ori A; Rosenwald A; Sahai E; von Eyss B
Nat Commun; 2018 Aug; 9(1):3115. PubMed ID: 30082728
[TBL] [Abstract][Full Text] [Related]
17. Tea domain transcription factor TEAD4 mitigates TGF-β signaling and hepatocellular carcinoma progression independently of YAP.
Luo W; Li Y; Zeng Y; Li Y; Cheng M; Zhang C; Li F; Wu Y; Huang C; Yang X; Kremerskothen J; Zhang J; Zhang C; Tu S; Li Z; Luo Z; Lin Z; Yan X
J Mol Cell Biol; 2023 Jun; 15(2):. PubMed ID: 36806855
[TBL] [Abstract][Full Text] [Related]
18. CK2-induced cooperation of HHEX with the YAP-TEAD4 complex promotes colorectal tumorigenesis.
Guo Y; Zhu Z; Huang Z; Cui L; Yu W; Hong W; Zhou Z; Du P; Liu CY
Nat Commun; 2022 Aug; 13(1):4995. PubMed ID: 36008411
[TBL] [Abstract][Full Text] [Related]
19. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K
Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813
[TBL] [Abstract][Full Text] [Related]
20. TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma.
Wang YQ; Wu DH; Wei D; Shen JY; Huang ZW; Liang XY; Cho WCS; Ma J; Lv J; Chen YP
Sci Adv; 2023 Jan; 9(1):eadd0960. PubMed ID: 36608137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]